Picture of Bioatla logo

BCAB Bioatla Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Bioatla, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-29-29.9-35.9-95.4
Depreciation
Non-Cash Items3.52-4.481.8724.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-10.723.8-3.367.42
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-35.3-9.64-36.3-62.2
Capital Expenditures-0.988-1.51-0.59-0.924
Purchase of Fixed Assets
Cash from Investing Activities-0.988-1.51-0.59-0.924
Financing Cash Flow Items0.019-0.005200-1.91
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.02427269.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-31.3-7.162356.37

Or unlock with your email

Or unlock with your email